Imatinib Mesylate in Treating Patients With Recurrent or Persistent Uterine Cancer

Clinical trial NCT00075400 · COMPLETED

Trial details

NCT number: NCT00075400
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Recurrent Uterine Sarcoma Uterine Carcinosarcoma

Start date: 2004-01-01
Primary completion: 2010-07-01
Enrollment: 26

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.